Approximately 71% of these are cutaneous T cell lymphomas (CTCL) and they comprise mycosis fungoides (MF), Sézary syndrome (SS), and cutaneous CD30+ lymphoproliferative disorder [4,5]. This evidence concerns the gene TNFRSF8 and primary cutaneous T-cell non-Hodgkin lymphoma.